We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
-16.6%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.04B
AUM Growth
-$3.41M
Cap. Flow
+$220M
Cap. Flow %
21.29%
Top 10 Hldgs %
43.95%
Holding
852
New
247
Increased
177
Reduced
137
Closed
202

Sector Composition

Rank Sector Weight
1 Healthcare 28.69%
2 Financials 13.57%
3 Materials 7.25%
4 Technology 4.61%
5 Industrials 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMAC.WS
426
DELISTED
The Music Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
TMAC.WS
$15K ﹤0.01%
171,925
+9,925
+6% +$1.76K
AGIO icon
427
CALL
Agios Pharmaceuticals
AGIO
$1.98B
$14K ﹤0.01%
30,000
MTZ icon
428
PUT
MasTec
MTZ
$22.1B
$14K ﹤0.01%
+20,000
New +$1.56M
VMCAW
429
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
$14K ﹤0.01%
+100,000
New +$16.6K
PORT.WS
430
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$14K ﹤0.01%
+96,822
New +$18.6K
REVHW
431
DELISTED
Revolution Healthcare Acquisition Corp. SAIL Warrant.
REVHW
$14K ﹤0.01%
59,180
+34,006
+135% +$11.4K
FVIV.WS
432
DELISTED
Fortress Value Acquisition Corp. IV Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
FVIV.WS
$14K ﹤0.01%
75,999
+25,999
+52% +$9.7K
MX icon
433
PUT
Magnachip Semiconductor
MX
$141M
$13K ﹤0.01%
+21,000
New +$361K
PIIIW icon
434
P3 Health Partners Inc Warrant
PIIIW
$182K
$13K ﹤0.01%
25,000
LCAHW
435
DELISTED
Landcadia Holdings IV, Inc. Warrant
LCAHW
$13K ﹤0.01%
40,517
+25,937
+178% +$11.6K
SLVRW
436
DELISTED
SilverSPAC Inc. Warrant
SLVRW
$13K ﹤0.01%
53,962
+3,962
+8% +$1.39K
TWCBW
437
DELISTED
Bilander Acquisition Corp. Warrant
TWCBW
$13K ﹤0.01%
+38,700
New +$15.9K
GSQB.WS
438
DELISTED
G Squared Ascend II Inc. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
GSQB.WS
$13K ﹤0.01%
+101,700
New +$26.7K
SPGS.WS
439
DELISTED
Simon Property Group Acquisition Holdings, Inc. Warrants, each exercisable for one Class A common stock at an exercise price of $11.50 per share
SPGS.WS
$13K ﹤0.01%
69,335
+2,000
+3% +$687
XLV icon
440
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$43.9B
$12K ﹤0.01%
+12,500
New +$1.64M
XFINW
441
DELISTED
ExcelFin Acquisition Corp Warrant
XFINW
$12K ﹤0.01%
65,615
+600
+0.9% +$136
ACAXW
442
DELISTED
Alset Capital Acquisition Corp Warrant
ACAXW
$12K ﹤0.01%
154,089
+129,089
+516% +$14.5K
VHAQ.WS
443
DELISTED
Viveon Health Acquisition Corp. Warrants to purchase one-half of a share of common stock at a price of $11.50 per whole share
VHAQ.WS
$12K ﹤0.01%
265,000
-10,202
-4% -$776
ANAC.WS
444
DELISTED
Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ANAC.WS
$12K ﹤0.01%
100,000
-2,171
-2% -$530
HCIIW
445
DELISTED
Hudson Executive Investment Corp. II Warrant
HCIIW
$12K ﹤0.01%
80,310
+4,310
+6% +$972
OEPWW
446
DELISTED
One Equity Partners Open Water I Corp. Warrant
OEPWW
$12K ﹤0.01%
+106,962
New +$22.6K
PPHPR
447
DELISTED
PHP Ventures Acquisition Corp. Rights
PPHPR
$12K ﹤0.01%
200,551
+351
+0.2% +$42
BMY icon
448
PUT
Bristol-Myers Squibb
BMY
$130B
$11K ﹤0.01%
+17,500
New +$1.33M
C icon
449
CALL
Citigroup
C
$228B
$11K ﹤0.01%
67,400
DNA icon
450
PUT
Ginkgo Bioworks
DNA
$505M
$11K ﹤0.01%
+308
New +$37.6K

Similar funds

Cowen and Company's Q2 2022 Portfolio in Review

As of Q2 2022, Cowen and Company held 852 positions worth $1.04B, down 0.33% from $1.04B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Cowen and Company deployed $220M of net new capital in Q2 2022, opening 247 new positions and adding to 177 existing holdings. Its largest new stake was Avidity Biosciences: 2,264,150 shares worth $32.9M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 40% a quarter earlier, followed by Financials and Materials.

On the sell side, the largest reduction was Social Capital Hedosophia Holdings Corp. VI, an estimated $16.9M trimmed.

  • Cowen and Company's largest Q2 2022 buy was Avidity Biosciences: 2,264,150 shares worth $32.9M.
  • Cowen and Company added most to ARK Innovation ETF in Q2 2022, an estimated $72.6M increase.
  • Cowen and Company's biggest Q2 2022 reduction was Social Capital Hedosophia Holdings Corp. VI, cutting an estimated $16.9M.
  • Cowen and Company fully exited Rivian in Q2 2022, selling an estimated $26.8M.
  • Cowen and Company's ten largest holdings make up 44% of its $1.04B portfolio in Q2 2022.
  • Cowen and Company opened 247 new positions and closed 202 in Q2 2022.
  • Cowen and Company's portfolio value fell 0.33% quarter-over-quarter to $1.04B.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.